Shotgun lipidomics-based characterization of the landscape of lipid metabolism in colorectal cancer.


Journal

Biochimica et biophysica acta. Molecular and cell biology of lipids
ISSN: 1879-2618
Titre abrégé: Biochim Biophys Acta Mol Cell Biol Lipids
Pays: Netherlands
ID NLM: 101731727

Informations de publication

Date de publication:
03 2020
Historique:
received: 31 07 2019
revised: 24 10 2019
accepted: 20 11 2019
pubmed: 4 12 2019
medline: 16 7 2020
entrez: 4 12 2019
Statut: ppublish

Résumé

Solid tumors are characterized by global metabolic alterations which contribute to their growth and progression. Altered gene expression profiles and plasma lipid composition suggested a role for metabolic reprogramming in colorectal cancer (CRC) development. However, a conclusive picture of CRC-associated lipidome alterations in the tumor tissue has not emerged. Here, we determined molar abundances of 342 species from 20 lipid classes in matched biopsies of CRC and adjacent normal mucosa. We demonstrate that in contrast to previous reports, CRC shows a largely preserved lipidome composition that resembles that of normal colonic mucosa. Important exceptions include increased levels of lyso-phosphatidylinositols in CRC and reduced abundance of ether phospholipids in advanced stages of CRC. As such, our observations challenge the concept of widespread alterations in lipid metabolism in CRC and rather suggest changes in the cellular lipid profile that are limited to selected lipids involved in signaling and the scavenging of reactive oxygen species.

Identifiants

pubmed: 31794862
pii: S1388-1981(19)30230-6
doi: 10.1016/j.bbalip.2019.158579
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

158579

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Yuting Wang (Y)

Center for Regenerative Therapies Dresden, Technische Universität (TU) Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Sebastian Hinz (S)

Department of Visceral Surgery, University Hospital Schleswig-Holstein, Christian-Albrechts-University Kiel, Kiel, Germany.

Ortrud Uckermann (O)

Neurosurgery, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.

Pia Hönscheid (P)

Institute of Pathology, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.

Witigo von Schönfels (W)

Department of Visceral Surgery, University Hospital Schleswig-Holstein, Christian-Albrechts-University Kiel, Kiel, Germany.

Greta Burmeister (G)

Department of Visceral Surgery, University Hospital Schleswig-Holstein, Christian-Albrechts-University Kiel, Kiel, Germany.

Alexander Hendricks (A)

Department of Visceral Surgery, University Hospital Schleswig-Holstein, Christian-Albrechts-University Kiel, Kiel, Germany.

Jacobo Miranda Ackerman (JM)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Gustavo B Baretton (GB)

Institute of Pathology, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.

Jochen Hampe (J)

Center for Regenerative Therapies Dresden, Technische Universität (TU) Dresden, Dresden, Germany; Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.

Mario Brosch (M)

Center for Regenerative Therapies Dresden, Technische Universität (TU) Dresden, Dresden, Germany; Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.

Clemens Schafmayer (C)

Department of Visceral Surgery, University Hospital Schleswig-Holstein, Christian-Albrechts-University Kiel, Kiel, Germany.

Andrej Shevchenko (A)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany. Electronic address: shevchenko@mpi-cbg.de.

Sebastian Zeissig (S)

Center for Regenerative Therapies Dresden, Technische Universität (TU) Dresden, Dresden, Germany; Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany. Electronic address: sebastian.zeissig@tu-dresden.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH